Press Release Zipalertinib Plus Chemotherapy Meets Primary Endpoint of Progression-Free Survival in Planned Interim Analysis of Phase 3 REZILIENT3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer Aug 12
Press Release Integra Strengthens Long-Term Growth Strategy in Australia and New Zealand with the Appointment of Mark Thompson as Managing Director Aug 12
Press Release Mobilewalla and SPACSphere Acquisition Corp. Announce Filing of Registration Statement on Form S-4 Regarding Proposed Business Combination Aug 12
Press Release Joybound People & Pets Announces Three New Board Members to Support Continued Growth and Impact Aug 12